Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

11 results

Sort by

List item

Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna) (updated)

CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021, , , Revision: 35, Authorised, Last updated: 03/02/2023
List item

Human medicine European public assessment report (EPAR): Comirnaty (updated)

Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020, , , Revision: 38, Authorised, Last updated: 03/02/2023
List item

Human medicine European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen) (updated)

adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S), COVID-19 virus infection
Date of authorisation: 11/03/2021, , , Revision: 27, Authorised, Last updated: 10/01/2023
List item

Human medicine European public assessment report (EPAR): Rinvoq

upadacitinib, Arthritis, Rheumatoid
Date of authorisation: 16/12/2019, , , Revision: 13, Authorised, Last updated: 13/12/2022
List item

Human medicine European public assessment report (EPAR): Rubraca

rucaparib camsylate, Ovarian Neoplasms
Date of authorisation: 23/05/2018, , , Revision: 11, Authorised, Last updated: 08/12/2022
List item

Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca)

ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021, , , Revision: 25, Authorised, Last updated: 30/11/2022
List item

Human medicine European public assessment report (EPAR): Jyseleca

filgotinib maleate, Arthritis, Rheumatoid
Date of authorisation: 24/09/2020, , , Revision: 8, Authorised, Last updated: 09/11/2022
List item

Human medicine European public assessment report (EPAR): Cibinqo

Abrocitinib, Dermatitis, Atopic
Date of authorisation: 09/12/2021, , , Revision: 2, Authorised, Last updated: 11/10/2022
List item

Human medicine European public assessment report (EPAR): Xeljanz

Tofacitinib, Arthritis, Rheumatoid
Date of authorisation: 22/03/2017,
Date of refusal: 25/04/2013, , Revision: 26, Authorised, Last updated: 04/10/2022
List item

Human medicine European public assessment report (EPAR): Olumiant

baricitinib, Arthritis, Rheumatoid
Date of authorisation: 13/02/2017, , Revision: 10, Authorised, Last updated: 29/06/2022
List item

Human medicine European public assessment report (EPAR): Esmya

ulipristal acetate, Leiomyoma
Date of authorisation: 22/02/2012, Revision: 16, Authorised, Last updated: 03/02/2021